Kimbell Royalty Partners LP
KRP · NYSE
$16.57+$0.18 (+1.10%)TodayMarket closed ·
Prev close $16.39
About KRP
- Employees
- 29
- Headquarters
- Fort Worth, Texas
- Listed
- Feb 3, 2017
- Sector
- Energy
- Industry
- Oil, Gas & Consumable Fuels
- Website
- kimbellrp.com
KRP key statistics
- Market cap
- 2.13B
- Price-earnings ratio
- 19.51
- Dividend yield
- 7.37%
- Average volume
- 864.71K
- Volume
- 957.23K
- Open price
- $16.50
- High today
- $16.63
- Low today
- $16.29
- 52 Week high
- $16.48
- 52 Week low
- $11.31
Kimbell Royalty Partners LP (KRP) at a glance
Kimbell Royalty Partners LP (KRP) last traded at $16.57, with a market cap of 2.13B, a price-to-earnings ratio of 19.51 and a dividend yield of 7.37%.
Today the stock has traded between $16.29 and $16.63. The current price is 1.7% above the day's low and 0.3% below its high.
Volume so far is 957.23K shares, in line with the average of 864.71K shares a day.
Over the past year Kimbell Royalty Partners LP has ranged from $11.31 to $16.48, and now sits 102% of the way up that range.
Kimbell Royalty Partners LP met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.40 per share against an estimate of $0.2329.
The average analyst price target is $20.74, 25.2% above the current price, from 4 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
75%of 4 analyst ratings say Buy
- Buy75.0%
- Hold25.0%
- Sell0.0%
Price target · 7 analystsAvg $20.74
- Low
- $17.17
- Now
- $16.57
- High
- $26.25
KRP earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 46.4% on average.
- Q3 FY24: reported $0.22 per share against an estimate of $0.1877
- Q4 FY24: reported -$0.48 per share against an estimate of $0.1717
- Q1 FY25: reported $0.20 per share against an estimate of $0.1559
- Q2 FY25: reported $0.02 per share against an estimate of $0.1473
- Q3 FY25: reported $0.19 per share against an estimate of $0.1315
- Q4 FY25: reported $0.21 per share against an estimate of $0.1234
- Q1 FY26: reported $0.04 per share against an estimate of $0.2052
- Q2 FY26: reported $0.40 per share against an estimate of $0.2329
KRP news
- Avi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Energy Stocks Delivering High-Dividend Yields
- Press releasePRNewswire
Kimbell Royalty Partners Announces Date for Third Quarter 2026 Earnings Release and Conference Call
- Avi Kapoor
Wall Street's Most Accurate Analysts Spotlight On 3 Energy Stocks Delivering High-Dividend Yields
- Press releasePRNewswire
Kimbell Royalty Partners Boosts 2026 Production Guidance
- Press releasePRNewswire
Kimbell Royalty Partners Closes $221.2 Million Drop Down Acquisition
- Press releasePRNewswire
Kimbell Royalty Partners Announces Record Second Quarter 2026 Results
- Press releasePRNewswire
Kimbell Royalty Partners, LP Announces $215.4 Million Drop Down Acquisition
Similar companies
Companies in the same industry as Kimbell Royalty Partners LP
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.